Drug-Eluting Stents in Acute Myocardial Infarction

Primary percutaneous coronary intervention (PCI), when performed by an experienced team in a timely fashion, is a better reperfusion therapy than in-hospital thrombolysis in patients who have acute myocardial infarction with ST-segment elevation.1,2 Although randomized trials of primary balloon angioplasty and primary stenting have not demonstrated a mortality benefit of primary stenting and have shown conflicting results with regard to the risk of reinfarction,3,4 primary stenting of the infarct-related lesion has become standard treatment in most patients undergoing primary PCI.Drug-eluting stents significantly reduce the risks of both restenosis and target-vessel revascularization after elective PCI, as compared with . . .